In this GEN panel discussion, three experts in cell and gene therapy development will share lessons and strategies learned ...

This immune response can be quantified and used to determine the potency (immunopotency) of vaccines, but the devil, as they say, is in the details.

InDevR's recent publication describes the development and performance of the VaxArray Influenza Pandemic HA potency assay for vaccines containing H5, H7, and H9 subtypes: Byrne-Nash, R. T. et al ...

In the study, the VaxArray Seasonal HA potency assay exhibited good overall accuracy, precision, and stability indication properties when compared to single radial immunodiffusion assay (SRID/SRD ...

Centivax, a biotechnology company that develops broad-spectrum vaccines to combat rapidly evolving pathogens, has announced a strategic collaboration with Emery Pharma, a leading contract research ...

Vaccine development involves a variety of assays to support vaccine research and development, from early preclinical studies to final production, quality control and lot release. ELISA-based assays ...

NEWARK, Del., Feb. 28, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project ...

NEWARK, Del., Feb. 28, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project ...

NEWARK, Del., Feb. 28, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project ...

NEWARK, Del., Feb. 28, 2023 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce approximately $1.7M in planned project ...